Key result
Patients treated with risperidone had a significantly longer mean nighttime QTcF interval (411.6 ms) compared to those on olanzapine (395.9 ms) and healthy controls (387.8 ms).
Why the study?
Do antipsychotics (risperidone or olanzapine) prolong the QT interval during nighttime in patients with schizophrenia compared to healthy controls?
Observational (n=106)
Do antipsychotics (risperidone or olanzapine) prolong the QT interval during nighttime in patients with schizophrenia compared to healthy controls?
Absolute Event Rate: 411.6% vs 387.8%
Risperidone is associated with significant nighttime QT prolongation compared to olanzapine and healthy controls, suggesting standard daytime ECGs may miss antipsychotic-induced QT prolongation.
Nighttime QT monitoring may warrant caution in antipsychotic users; leaves open agent-specific circadian effects for prospective study.
Most antipsychotic agents can cause QT prolongation, which causes torsades de pointes. The QT interval in healthy subjects is longer during nighttime than during daytime. The QT interval of patients treated with antipsychotics may be prolonged during nighttime, and the effects of antipsychotics on the QT interval may differ between antipsychotics. This study investigated the circadian dynamics of the QT interval in patients treated with antipsychotics and healthy controls, using a 24-hour Holter electrocardiogram in a clinical setting. Sixty-six patients with a diagnosis of schizophrenia that were treated with risperidone or olanzapine and 40 healthy volunteers were enrolled. The QT intervals were corrected using the Fridericia formula (QTcF = QT / RR). Mean ± SD nighttime QTcFs were 411.6 ± 29.0, 395.9 ± 21.2, and 387.8 ± 19.0 milliseconds (ms) in the risperidone, olanzapine, and control groups, respectively. The mean daytime QTcFs were 397.7 ± 23.4, 392.4 ± 18.9, and 382.6 ± 17.3 ms, respectively. The mean nighttime QTcF of the risperidone group was significantly longer than that of the olanzapine and control groups, although there was no significant difference in the mean daytime QTcF between the risperidone and olanzapine groups. The current study used 24-hour Holter electrocardiograms to reveal significantly longer QT intervals in the risperidone group especially during nighttime. In clinical practices, evaluations of the QT interval have been conducted over short periods in the daytime, but it is believed that such methods may not be able to fully elucidate the effects of antipsychotics on the QT interval.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2011) conducted an observational in Schizophrenia (n=106). Risperidone and olanzapine vs. Healthy controls was evaluated on Mean nighttime QTcF interval. Patients treated with risperidone had a significantly longer mean nighttime QTcF interval (411.6 ms) compared to those on olanzapine (395.9 ms) and healthy controls (387.8 ms).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: